State of Wisconsin Investment Board
BTAI icon

State of Wisconsin Investment Board’s BioXcel Therapeutics BTAI Stock Holding History

State of Wisconsin Investment Board’s Portfolio BTAI Stock Details BTAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,789
Closed -$191K – 2522
2023
Q2 		$191K Buy
1,789
+296
+20% +$98.6K ﹤0.01% 2162
2023
Q1 		$446K Sell
1,493
-2,047
-58% -$874K ﹤0.01% 1920
2022
Q4 		$1.22M Sell
3,540
-793
-18% -$192K ﹤0.01% 1434
2022
Q3 		$819K Sell
4,333
-1,038
-19% -$241K ﹤0.01% 1651
2022
Q2 		$1.13M Buy
5,371
+2,483
+86% +$522K ﹤0.01% 1567
2022
Q1 		$966K Buy
2,888
+1,944
+206% +$563K ﹤0.01% 1651
2021
Q4 		$307K Hold
944
– – ﹤0.01% 1942
2021
Q3 		$458K Hold
944
– – ﹤0.01% 1721
2021
Q2 		$439K Hold
944
– – ﹤0.01% 1717
2021
Q1 		$652K Sell
944
-381
-29% -$306K ﹤0.01% 1492
2020
Q4 		$979K Sell
1,325
-219
-14% -$171K ﹤0.01% 1333
2020
Q3 		$1.07M Buy
1,544
+738
+92% +$554K ﹤0.01% 1274
2020
Q2 		$684K Buy
806
+137
+20% +$89.3K ﹤0.01% 1334
2020
Q1 		$239K Buy
+669
New +$240K ﹤0.01% 1548

Other funds holding BTAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State of Wisconsin Investment Board's BTAI Position: Q3 2023 in Review

State of Wisconsin Investment Board sold out of BioXcel Therapeutics (BTAI) in Q3 2023, closing a stake of 1,789 shares — an estimated $191K sold.

State of Wisconsin Investment Board first reported a position in BTAI in Q1 2020 and held it in 14 quarters. The position peaked at $1.22M in Q4 2022. 85 funds tracked by Wall St. Rank hold BTAI as of Q3 2023.

  • State of Wisconsin Investment Board reported no remaining BioXcel Therapeutics position as of Q3 2023 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 1,789 BioXcel Therapeutics shares in Q3 2023, an estimated $191K.
  • State of Wisconsin Investment Board first reported a position in BioXcel Therapeutics in Q1 2020 and held it in 14 quarters.
  • State of Wisconsin Investment Board's BioXcel Therapeutics position peaked at $1.22M in Q4 2022.
  • 85 funds tracked by Wall St. Rank held BioXcel Therapeutics as of Q3 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2023, filed 14 Nov 2023.